Tabula rasa healthcare, inc. (TRHC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Cash flows from operating activities:
Net loss

-35,894

-32,436

-36,177

-17,657

-40,154

-47,269

-25,802

-30,053

-2,710

12,791

-3,413

-9,720

-8,323

-5,521

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

37,890

34,276

29,211

24,165

19,053

16,802

15,892

13,962

11,795

9,512

7,430

6,540

5,876

5,115

0

0

0

Amortization of deferred financing costs and debt discount

12,554

10,877

7,726

4,665

1,657

103

86

87

91

92

96

149

721

1,279

0

0

0

Payment of imputed interest on debt

-

-

-

-

-

-

-

-

-

-

-

-

-

3,893

0

0

0

Deferred taxes

-16,339

-16,353

-9,861

-7,214

-6,935

-3,648

-6,859

-12,772

-9,656

-9,467

-6,619

603

571

498

0

0

0

Stock-based compensation

27,563

27,278

24,223

19,994

15,268

10,361

8,097

6,040

6,876

8,752

11,545

10,829

7,944

4,250

0

0

0

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-639

0

0

0

Change in fair value of acquisition-related contingent consideration

3,340

3,816

13,599

3,670

37,123

49,468

33,252

42,594

7,327

-6,173

476

-400

-371

-338

0

0

0

Acquisition-related contingent consideration paid

-

24,480

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other noncash items

-

-20

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities, net of effect from acquisitions:
Accounts receivable, net

2,412

-1,444

2,838

7,644

9,429

9,456

7,441

3,871

2,887

1,765

386

2,798

3,094

756

0

0

0

Inventories

1,424

106

201

295

1,040

799

832

186

-350

-116

172

353

732

607

0

0

0

Rebates receivable

-

-

-

-

-

-

-

-

-

-

0

0

-732

-

0

0

0

Prepaid expenses and other current assets

1,051

7,705

-638

967

3,175

1,651

4,602

2,081

-65

-295

687

352

896

783

0

0

0

Other assets

-139

269

780

796

1,096

460

0

0

0

-

-

-

-34

-1

0

0

0

Accounts payable

-4,823

-7,809

-1,402

-4,292

-466

-778

0

0

0

-

-

-

-

665

0

0

0

Accrued expenses and other liabilities

615

5,712

-348

6,460

1,999

2,599

7,773

2,456

5,394

2,626

1,766

1,556

-777

-1,168

0

0

0

Other long-term liabilities

-80

-80

454

531

535

507

-29

-120

260

410

664

-1,352

589

2,205

0

0

0

Net cash used in operating activities

20,034

-5,815

-224

-3,796

-11,025

15,830

15,851

15,253

16,540

18,308

15,997

6,676

4,216

6,774

0

0

0

Cash flows from investing activities:
Purchases of property and equipment

7,218

7,474

6,706

5,932

4,885

4,988

4,169

3,917

3,560

3,303

3,484

2,862

2,266

3,813

0

0

0

Software development costs

16,085

14,487

12,279

10,021

7,128

5,558

4,655

3,955

3,574

3,314

2,876

2,792

2,406

1,854

0

0

0

Proceeds from repayment of note receivable

-

1,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Acquisitions of businesses, net of cash acquired

-

158,762

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-24,541

-180,925

-189,201

-199,990

-203,001

-43,808

-30,833

-49,310

-41,585

-41,068

-45,412

-11,254

-10,301

-11,096

0

0

0

Cash flows from financing activities:
Payments for repurchase of common stock

-

-

-

-

-

2,866

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

3,818

3,702

3,436

2,886

3,640

3,523

2,876

2,474

1,350

480

0

0

0

-

-

-

-

Payments for employee taxes for shares withheld

-

-

-

-

-

-

-

-

-

2,123

0

0

0

-

-

-

-

Payments for debt financing costs

-

9,630

9,704

9,650

9,591

175

104

205

205

221

0

0

0

-

-

-

-

Borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

6,000

0

0

0

Repayments of line of credit

-

45,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments of equity offering costs

-

-

-

-

-

364

597

590

590

365

1,287

2,496

3,077

3,346

0

0

0

Payments of acquisition-related contingent consideration

-

-

-

-

-

-

-

-

-

2,098

1,498

1,498

1,498

1,895

0

0

0

Payments of acquisition-related consideration

-

-

-

0

0

-

-

0

0

-

-

-

-

180

0

0

0

Repayments of long-term debt and finance leases

741

968

1,029

1,078

1,073

1,051

0

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible senior subordinated notes

-

325,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of warrants

-

65,910

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of convertible note hedges

-

101,660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of long-term debt

-

-

-

-

-

-

-

-

-

-

34,285

45,039

46,197

47,369

0

0

0

Net cash provided by financing activities

-7,475

208,292

226,547

253,215

263,653

42,577

22,990

38,519

26,492

28,845

33,361

2,890

6,403

6,441

0

0

0

Net (decrease) increase in cash and restricted cash

-11,982

21,552

37,122

49,429

49,627

14,599

8,008

4,462

1,447

6,085

3,946

-1,688

318

2,119

0

0

0

Supplemental disclosure of cash flow information:
Acquisition of equipment under capital leases

-

-

-

-

-

442

0

0

0

-

-

574

1,337

1,605

0

0

0

Purchases of property and equipment and software development included in accounts payable and accrued expenses

-1,358

19

588

14

1,385

175

880

439

600

540

185

740

621

373

0

0

0

Deferred offering costs included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

132

0

0

0

Cash paid for interest

5,541

3,181

3,646

963

1,161

720

704

614

591

599

702

6,948

7,737

8,457

0

0

0

Cash paid for taxes

426

381

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest costs capitalized to property and equipment and software development costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Employee payroll taxes on exercise of stock options included in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Stock issued in connection with acquisitions

-

9,504

9,504

9,504

9,504

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0